NCT02411825 - Multiple Ascending Dose Study in Healthy Male Subjects and Overweight to Obese Male and Female Type 2 Diabetes Mellitus (T2DM) Patients | Biotech Hunter

Enrollment

Participants

Timeline

Start Date

March 31, 2015

Primary Completion Date

January 31, 2016

Study Completion Date

January 31, 2016

Conditions

Type 2 Diabetes Mellitus

Interventions

DRUG

SAR425899

"Pharmaceutical form: solution for injection~Route of administration: subcutaneous"

DRUG

placebo

"Pharmaceutical form: solution for injection~Route of administration: subcutaneous"

DRUG

metformin

"Pharmaceutical form: tablet~Route of administration: oral"

Trial Locations (1)

Investigational Site Number 276001, Berlin